2014
New Modalities in the Chronic Ischemic Diabetic Foot Management
Shalaby SY, Blume P, Sumpio BE. New Modalities in the Chronic Ischemic Diabetic Foot Management. Clinics In Podiatric Medicine And Surgery 2014, 31: 27-42. PMID: 24296016, DOI: 10.1016/j.cpm.2013.09.009.Peer-Reviewed Original ResearchMeSH KeywordsCell- and Tissue-Based TherapyDiabetic FootEpidermal Growth FactorFibrinolytic AgentsGranulocyte Colony-Stimulating FactorHumansProstaglandinsConceptsNontraumatic lower limb amputationsDiabetic foot managementIschemic diabetic footPeripheral arterial diseaseDiabetic foot ulcersLower limb amputationNew modalityLives of patientsPathophysiologic causesDiabetic populationArterial diseaseFoot ulcersDiabetic footConventional therapyFoot managementDiabetic ulcersLimb amputationImprovement of qualityRecovery periodUlcersModalitiesComplicationsMajor contributorPatientsAmputation
2013
Omental Vein Catheter Thrombolysis for Acute Porto-Mesenteric Vein Thrombosis
Fonseca AL, Cleary MA, Cholewczynski W, Sumpio BE, Atweh NA. Omental Vein Catheter Thrombolysis for Acute Porto-Mesenteric Vein Thrombosis. Annals Of Vascular Surgery 2013, 27: 497.e1-497.e4. PMID: 23566871, DOI: 10.1016/j.avsg.2012.09.009.Peer-Reviewed Original Research
2000
Vascular drugs in the new millennium11No competing interests declared.
Frangos S, Chen A, Sumpio B. Vascular drugs in the new millennium11No competing interests declared. Journal Of The American College Of Surgeons 2000, 191: 76-92. PMID: 10898187, DOI: 10.1016/s1072-7515(00)00292-1.Peer-Reviewed Original ResearchAbciximabAnimalsAnistreplaseAntibodies, MonoclonalAnticoagulantsAspirinChondroitin SulfatesClopidogrelDermatan SulfateDrug CombinationsFibrinolytic AgentsHeparin, Low-Molecular-WeightHeparitin SulfateHumansImmunoglobulin Fab FragmentsIntermittent ClaudicationPlatelet Aggregation InhibitorsStreptokinaseTiclopidineVascular DiseasesVenous Thrombosis